Dr Reddy’s plans 'beyond-the-pill' strategy for Semaglutide
With multiple rivals set to enter the generic race, Dr Reddy’s lines up obesity centres, nutrition products and patient support alongside its Day 1 launch, focusing on market creation beyond pricing.
With multiple rivals set to enter the generic race, Dr Reddy’s lines up obesity centres, nutrition products and patient support alongside its Day 1 launch, focusing on market creation beyond pricing.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
